英文摘要 |
Background: Group B Streptococcus or Streptococcus agalactiae (GBS) is a common pathogen associated with urogenital system infection in 25% of women. Neonatal GBS disease generally manifests as pneumonia, sepsis, and meningitis during delivery. To investigate the molecular epidemiological distribution of GBS in locally pregnant women, GBS strains were obtained from routinely screened-pregnant women at Chang Bing Show Chwan Memorial Hospital (CBSCMH) for further genetic based-molecular analysis. Materials and methods: We investigated GBS collected in 2017 at Chang Bing Show Chwan Memorial Hospital by analyzing antibiotic resistance, capsular polysaccharide serotyping, carriage of hvgA gene, and multi-locus gene sequence typing (MLST). Results: In total, 218 out of 957 vaginal swabs were GBS positive (22%), and the leading three serotypes were type III (25.2%), type VI (22.5%), and type V (14.7%). Then, 105 selected strains were further investigated by MLST analysis. The top three main sequence types (ST) were ST1 / Serotype VI (20%), followed by ST12 / Serotype Ib (8.6%), and ST17 / Serotype III (7.6%). Regarding antimicrobial resistance, all strains remained 100% sensitive to penicillin, but highly resistant to erythromycin (41.3%) and clindamycin (39.4%). In addition, all 8 GBS strains with ST17 type carried the hvgA virulence gene (100%). Conclusion: This study shows that the positivity rate of GBS among pregnant women in Taiwan was 22%, and serotypes III and VI were the leading two serotypes. Although the proportion of ST17 was not high, but they all contained the virulent hvgA gene. At present, penicillin is still recommended as the first choice for the treatment or prevention of beta-streptococcal infection in pregnant women. |